
Aspen Pharma’s High-Containment Manufacturing Facility, Port Elizabeth
In May 2018, pharmaceutical manufacturing firm Aspen Pharma opened a high-containment facility in Port Elizabeth, South Africa.
Unither is an independent pharmaceutical company specialising in the development and contract manufacture of the pharmaceutical formulations that patients and prescribers prefer :
Unither undergoes regular inspections by national and international health authorities. It is compliant with European cGMP guidelines and has achieved ISO:13485 certification. We export to over 15 countries and attach great importance to the quality of our customer service.
As Europe’s leading manufacturer of sterile single-dose units, Unither has over 60 different moulds (from 0.25ml to 500ml) and can produce up to 1.5 billion units per year.
We can supply effervescent tablets packaged in tubes or in blister packs.
As Europe’s joint leader in the manufacturing of effervescent tablets, Unither is increasing its production capacity to meet rising market needs.
The stick-pack presentation is an attractive alternative to liquid sachet or to any currently bottled product in this emerging market.
Unither has invested in a high-performance, flexible production tool located on a site with in-depth experience of liquid and paste formulations.
Located in Bordeaux within an innovation and healthcare cluster, Unither Développement possesses acknowledged expertise in the formulation and analytical development, as well as the production and packaging, of low scale batches.
In May 2018, pharmaceutical manufacturing firm Aspen Pharma opened a high-containment facility in Port Elizabeth, South Africa.
Unither will be attending the CPhI/ICSE fair that will take place from 13-15 October in Madrid, Spain. Those interested in learning more about Unither services can meet us at booth 8E72, or contact us directly to pre-arrange a meeting. Unither is an independent pharmaceutical company sp
5 October 2009Unither has recently modified its equity: ING Parcom has replaced Société Générale Capital Europe (SGCE) as main shareholder. ING Parcom is a private equity company like SGCE. This move will enable Unither to pursue its development through organic growth or acquisiti
5 December 2006Thank you for submitting the form. Your enquiry will be submitted to the company.
Thank you for subscribing to Pharmaceutical Technology